BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pierre Fabre Donates the Majority Equity Interest in his Company to his Foundation


9/5/2008 9:05:37 AM

PARIS, September 5 /PRNewswire/ -- Faithful to the commitment made in 2005 to his employees, Mr. Pierre Fabre asked the Pierre Fabre Foundation's board of directors to accept the donation of 100% of the equity of Pierre Fabre Participation, a holding company with a 60% share in Laboratoires Pierre Fabre.

The aim of this operation is to secure the long-term independence of Pierre Fabre SA, a company founded in 1961 in Castres with a turnover of EUR 1.7 billion in pharmaceuticals, family medical products and dermocosmetics.

At the same time, Mr. Pierre Fabre expressed his intention to transform Pierre Fabre SA into a company under a Supervisory Committee, chaired by him, with Mr. Garnier heading the management board.

Mr. Jean-Pierre Garnier, 60, was CEO of the world's second biggest pharmaceuticals group, GlaxoSmithKline, until last May. An Officer of the Legion of Honour, Mr. Garnier has been a member of the French Healthcare Industries Strategic Council since the organisation was founded.

When announcing this decision, Mr. Pierre Fabre stated: "we are fortunate to have a man with so much experience in the global pharmaceutics arena in the person of Jean-Pierre Garnier, who will enable us to successfully sustain the considerable R&D efforts the company has been making over the past few years and amplify its growth."

About Pierre Fabre SA

Pierre Fabre SA, is a leading independent Pharmaceutical, Dermo-Cosmetic and Health & Beauty Company. Pierre Fabre specializes in the development of medicines (oncology, cardiology, central nervous system, urology and dermatology), dermo-cosmetic and hair care products derived from natural substances. Pierre Fabre currently has nearly 10,000 employees globally and an annual turnover of EUR1.7 billion (about $2.55 billion US). Pierre Fabre dedicates 25 percent of its sales to Research and Development. Pierre Fabre brands include Avene, A-Derma, Ducray, Klorane, Galenic, Elancyl and Rene Furterer. The Company has established several philanthropic foundations devoted to the preservation of plants and their heritage as well as humanitarian efforts.

website: http://www.pierre-fabre.com.

The Pierre Fabre Foundation is a registered charity founded by order of the prime minister on 8 April 1999. It is chaired by Mr. Pierre Fabre and works to promote good pharmaceutical practice and improve healthcare in developing countries.

CONTACT: Press Contact: catherine.de.rohan.chabot@pierre-fabre.com,
christelle.touchet@pierre-fabre.com, Press relation: +33(0)149-10-81-33



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES